Related Experiment Video
Updated: Aug 24, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Comparing the representation of medicinal products in RxNorm and SNOMED CT - Consequences on interoperability
Jean Noel Nikiema1, Olivier Bodenreider2
1Bordeaux Population Health Research Center, ERIAS, Univ. Bordeaux, Inserm UMR 1219, F-33000, Bordeaux, France.
Objectives:
To compare the representation of medicinal products in RxNorm and SNOMED CT and assess the consequences on interoperability.
Methods:
To compare the two models, we manually establish equivalences between the types and definitional features of medicinal products entities in RxNorm and SNOMED CT. We highlight their similarities and differences.
Results:
Both models share major definitional features including ingredient (or substance), strength and dose form. SNOMED CT is more rigorous and better aligned with international standards. In contrast, RxNorm contains implicit knowledge, simplifications and ambiguities, but its model is simpler.
Conclusions:
Since their models are largely compatible, medicinal products from RxNorm and SNOMED CT are expected to be interoperable. However, specific aspects of the alignment between the two models require particular attention.
More Related Videos
Related Concept Videos
Drug Nomenclature
Bioequivalence: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Analysis of Population Pharmacokinetic Data
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Drug Classes and Categories

